Zika virus infection intensified due to dengue antibodies presence, preliminary research suggests

Zika virus infection intensified due to dengue antibodies Zika virus infection intensified due to dengue antibodies presence, according to preliminary research. There are four serotypes (strains) of dengue virus, and infection with one of the serotypes generally leads to a self-resolving disease. To answer the question of whether dengue virus could impact Zika virus, the researchers used two broadly neutralizing anti-dengue virus monoclonal antibodies that had been previously taken from patients who recovered from infection.

The researchers found when two anti-dengue virus monoclonal antibodies bind with Zika virus, the Zika infection worsened 100-fold. When dengue antibodies were absent, Zika RNA levels were low.


The findings are still preliminary and must be replicated in animal and human models. If the results remain the same, this could imply more dangerous infections observed in countries that have cases of both Zika and dengue – Brazil, for example.

Dengue fever program may halt Zika transmission

A dengue fever program, which aims to stop dengue virus, may also help halt Zika virus. The findings come from researchers in north Queensland who have been working on a program to combat dengue fever and its transmission.

The program consists of infecting mosquitoes with dengue-resistant bacteria spread through the mating process. The researchers have already seen a dramatic reduction in dengue, and no local outbreaks were reported in 2014 – the mosquitoes were first unleashed in 2014.

The researchers believe the bacteria could be modified for other mosquito-transmitted viruses to help prevent future outbreaks as well. Professor Scott O’Neill from Eliminate Dengue said, “That includes dengue, yellow fever, Zika, and chikungunya. Our trials are well positioned to measure Zika and dengue at the same time.”

Related Reading:

Zika virus fact sheet

Zika virus was first discovered in 1947, and its name is derived from the Zika forest in Uganda where it was found. Human cases of Zika virus were first reported in 1952, but until last year cases have been seen almost exclusively in tropical areas. Continue reading…


Zika virus, dengue, and malaria risk reduced after genetically modified mosquitoes released in affected areas, studies show

Zika virus, dengue, and malaria risk is reduced once genetically modified mosquitoes are released in affected areas. The World Health Organization (WHO) gave a statement on deploying genetically modified mosquitoes stating, “Given the magnitude of the Zika crisis, WHO encourages affected countries and their partners to boost the use of both old and new approaches to mosquito control as the most immediate line of defense.” Continue reading…


Author Bio

Devon Andre has been involved in the health and dietary supplement industry for a number of years. Devon has written extensively for Bel Marra Health. He has a Bachelor of Forensic Science from the University of Windsor, and went on to complete a Juris Doctor from the University of Pittsburgh. Devon is keenly aware of trends and new developments in the area of health and wellness. He embraces an active lifestyle combining diet, exercise and healthy choices. By working to inform readers of the options available to them, he hopes to improve their health and quality of life.